| Primary |
| Vitamin Supplementation |
27.6% |
| Ileus |
6.9% |
| Macular Degeneration |
6.9% |
| Weight Decreased |
6.9% |
| Age-related Macular Degeneration |
3.4% |
| Anticoagulant Therapy |
3.4% |
| Coagulopathy |
3.4% |
| Drug Therapy |
3.4% |
| Drug Use For Unknown Indication |
3.4% |
| Hiv Infection |
3.4% |
| Infertility Female |
3.4% |
| Neck Pain |
3.4% |
| Nutritional Supplementation |
3.4% |
| Prenatal Care |
3.4% |
| Prostatic Disorder |
3.4% |
| Relaxation Therapy |
3.4% |
| Sleep Disorder |
3.4% |
| Supplementation Therapy |
3.4% |
| Vomiting |
3.4% |
|
| Pharmaceutical Product Complaint |
12.5% |
| Blood Glucose Increased |
8.3% |
| Nausea |
8.3% |
| Anaphylactic Shock |
4.2% |
| Diarrhoea |
4.2% |
| Drug Interaction |
4.2% |
| Genital Burning Sensation |
4.2% |
| Headache |
4.2% |
| Memory Impairment |
4.2% |
| Nasopharyngitis |
4.2% |
| Product Taste Abnormal |
4.2% |
| Rash Pruritic |
4.2% |
| Respiratory Rate Increased |
4.2% |
| Retching |
4.2% |
| Sepsis |
4.2% |
| Skin Ulcer |
4.2% |
| Sputum Discoloured |
4.2% |
| Stomach Discomfort |
4.2% |
| Tongue Dry |
4.2% |
| Tremor |
4.2% |
|
| Secondary |
| Depression |
13.8% |
| Product Used For Unknown Indication |
12.5% |
| Drug Use For Unknown Indication |
12.1% |
| Diabetes Mellitus |
10.1% |
| Parenteral Nutrition |
8.1% |
| Sleep Disorder |
6.7% |
| Hyperemesis Gravidarum |
4.4% |
| Tachyarrhythmia |
4.0% |
| Ill-defined Disorder |
3.4% |
| High Density Lipoprotein Decreased |
2.7% |
| Hot Flush |
2.7% |
| Night Sweats |
2.7% |
| Vitamin Supplementation |
2.7% |
| Weight Increased |
2.7% |
| Blood Cholesterol Increased |
2.4% |
| Hypertension |
2.4% |
| Dyslipidaemia |
1.7% |
| Hypocholesterolaemia |
1.7% |
| Migraine |
1.7% |
| Pain |
1.7% |
|
| Myocardial Infarction |
13.5% |
| Weight Increased |
10.8% |
| Stomach Discomfort |
8.1% |
| Headache |
5.4% |
| Pain In Extremity |
5.4% |
| Persistent Foetal Circulation |
5.4% |
| Pharmaceutical Product Complaint |
5.4% |
| Photosensitivity Reaction |
5.4% |
| Renal Failure Acute |
5.4% |
| Speech Disorder |
5.4% |
| Weight Decreased |
5.4% |
| Abdominal Distension |
2.7% |
| Abdominal Pain |
2.7% |
| Arthritis |
2.7% |
| Cardiac Disorder |
2.7% |
| Choking |
2.7% |
| Congenital Musculoskeletal Anomaly |
2.7% |
| Convulsion |
2.7% |
| Dependence |
2.7% |
| Drug Dependence |
2.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
48.5% |
| Rheumatoid Arthritis |
5.1% |
| Drug Use For Unknown Indication |
4.5% |
| Hypertension |
4.5% |
| Crohn's Disease |
4.3% |
| Vitamin Supplementation |
4.0% |
| Prophylaxis |
3.0% |
| Pain |
3.0% |
| Supplementation Therapy |
2.8% |
| Depression |
2.4% |
| Gastrooesophageal Reflux Disease |
2.4% |
| Blood Cholesterol Increased |
2.3% |
| Atrial Fibrillation |
1.9% |
| Insomnia |
1.9% |
| Osteoporosis |
1.8% |
| Hepatitis C |
1.7% |
| Multiple Myeloma |
1.7% |
| Anxiety |
1.4% |
| Multiple Sclerosis |
1.4% |
| Psoriasis |
1.4% |
|
| Vomiting |
11.5% |
| Weight Decreased |
10.3% |
| Injection Site Pain |
6.8% |
| Weight Increased |
6.5% |
| Drug Ineffective |
6.3% |
| Pain |
5.9% |
| Pulmonary Embolism |
5.8% |
| Nausea |
4.9% |
| Rash |
4.8% |
| Urinary Tract Infection |
4.2% |
| Pruritus |
4.1% |
| Vision Blurred |
3.9% |
| Headache |
3.3% |
| White Blood Cell Count Decreased |
3.3% |
| Pneumonia |
3.3% |
| Pyrexia |
3.3% |
| Tremor |
3.0% |
| Pain In Extremity |
3.0% |
| Fatigue |
2.9% |
| Death |
2.9% |
|
| Interacting |
| Product Used For Unknown Indication |
33.3% |
| Depression |
11.1% |
| Diabetes Mellitus |
11.1% |
| Blood Cholesterol Increased |
8.3% |
| Hypertension |
8.3% |
| Rheumatoid Arthritis |
5.6% |
| Tachyarrhythmia |
5.6% |
| Abdominal Discomfort |
2.8% |
| Candida Infection |
2.8% |
| Dyslipidaemia |
2.8% |
| Encephalopathy |
2.8% |
| Fungal Infection |
2.8% |
| High Density Lipoprotein Decreased |
2.8% |
|
| Drug Interaction |
50.0% |
| Haemolytic Anaemia |
16.7% |
| Myocardial Infarction |
16.7% |
| Speech Disorder |
16.7% |
|
